MOTS-c is a 16-amino-acid peptide with an unusual origin: it is encoded not by nuclear DNA, but by the mitochondrial genome. It belongs to a small class of molecules known as mitochondrial-derived peptides, and it is studied primarily in the context of metabolic regulation.

What makes MOTS-c unusual?

Almost every protein in a human cell is encoded in the nucleus. Mitochondria retain a small circular genome of their own, historically thought to encode only a handful of components of the respiratory chain. MOTS-c — short for Mitochondrial Open reading frame of the Twelve S rRNA type-c — is encoded within that mitochondrial DNA.

Its discovery contributed to a broader reassessment of mitochondria: not merely as energy-producing organelles, but as participants in cellular signalling.

What is it studied for?

Research on MOTS-c concentrates on metabolic pathways, particularly:

• AMPK signalling — the AMP-activated protein kinase pathway, a central sensor of cellular energy status.
• Folate–methionine metabolism — the one-carbon pathway, which preclinical work has linked to MOTS-c activity.
• Glucose handling and insulin sensitivity in animal models.
• Exercise physiology — MOTS-c expression has been reported to change in response to metabolic stress.

Retrograde signalling

The concept underlying much of this work is retrograde signalling: communication travelling from the mitochondrion back to the nucleus, rather than the other way around. MOTS-c has been reported to translocate to the nucleus under metabolic stress, where it may influence gene expression. If that model holds, it represents a genuine channel by which mitochondria report their state to the rest of the cell.

It is worth being careful here. This is an active research area, and much of the mechanistic detail remains contested.

Where it sits in a catalogue

MOTS-c is usually filed under metabolic and cellular research, alongside NAD+. The two are frequently mentioned together because both concern mitochondrial function and cellular energetics — though MOTS-c is a peptide and NAD+ is a coenzyme, so their mechanisms have nothing structurally in common.

A note on the evidence base

MOTS-c was first described relatively recently. The literature is dominated by cell and animal models, and human data is limited. Claims that outrun that evidence are common online. For laboratory purposes, it is best treated as a tool for probing AMPK and mitochondrial signalling, not as a compound with established outcomes.

Availability

We supply MOTS-c 10mg for laboratory research. For guidance on preparing it for use, see our Reconstitution & Storage guide.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

A peptide advertised as “99% pure” tells you less than it appears to. Purity is a measurement, and a measurement is only meaningful once you know what was measured, by what method, and against what. This article explains the two analytical techniques you will encounter on a Certificate of Analysis, and what each can and cannot tell you.

The two questions

Analytical verification answers two separate questions, and they require different instruments:

• Is this the right molecule? Answered by mass spectrometry.
• How much of the sample is that molecule? Answered by HPLC.

A certificate showing only one of these is incomplete. Identity without purity, or purity without identity, leaves an obvious gap.

HPLC: the purity question

High-Performance Liquid Chromatography separates a mixture by pushing it through a column packed with a stationary material. Different molecules travel at different speeds and emerge at different times. A detector records what comes off, producing a chromatogram: a baseline with peaks.

The target peptide should appear as one dominant peak. Purity is calculated as the area of that peak as a percentage of the total area of all peaks. So “99% by HPLC” means the main peak accounts for 99% of the detected signal.

The important caveat: HPLC only sees what the detector detects. Most peptide analysis uses ultraviolet detection, which responds to particular chemical bonds. Residual salts, water, and some solvents may be effectively invisible. A peptide can be 99% pure by HPLC while a meaningful fraction of the vial’s mass is not peptide at all — a phenomenon sometimes described as the difference between peptide purity and peptide content.

Mass spectrometry: the identity question

Mass spectrometry ionises the sample and measures the mass-to-charge ratio of the resulting ions. Because every peptide has a calculable theoretical molecular weight determined by its amino acid sequence, the observed mass can be compared against the expected value.

If they match, the molecule is almost certainly the intended one. If they do not, something is wrong — a truncated sequence, a modification, or an entirely different compound. This is precisely how you would distinguish CJC-1295 with DAC from the version without it, since their molecular weights differ.

Reading a certificate critically

A few things worth checking:

• Is there a batch number, and does it match the vial in your hand? A generic certificate not tied to a specific batch is of limited value.
• Is the chromatogram shown, or only a number? The trace itself reveals whether the main peak is clean or shouldered.
• Does the observed mass match the theoretical mass? Both should be printed.
• Who performed the analysis? In-house and independent third-party testing are not equivalent claims.

Why this matters more here than elsewhere

Research peptides are supplied as white powders that are visually indistinguishable from one another. There is no sensory check available. Documentation is the only mechanism by which identity and purity can be established, which is why we cover it in detail in why Certificates of Analysis matter and on our Quality & Testing page.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

NAD+ (nicotinamide adenine dinucleotide) is not a peptide at all. It is a coenzyme found in every living cell, and it appears in peptide catalogues because it sits at the centre of cellular energy metabolism — a field that overlaps heavily with peptide research.

What is NAD+?

NAD+ is a dinucleotide built from two nucleotides joined through their phosphate groups. Its function is to carry electrons. In doing so it cycles between two states: the oxidised form (NAD+) and the reduced form (NADH). That cycle underpins the reactions by which cells extract energy from nutrients.

Why is it studied?

NAD+ has two broadly distinct roles, and the second is what drives most current research interest.

As an electron carrier, it is consumed and regenerated continuously in glycolysis, the citric acid cycle and oxidative phosphorylation. This role is textbook biochemistry.

As a substrate, NAD+ is consumed — not recycled — by several enzyme families, notably the sirtuins and PARPs. Sirtuins are implicated in research on cellular stress responses and metabolic regulation. PARPs are involved in DNA repair. Because these enzymes use NAD+ up, its availability becomes a limiting factor for their activity.

The ageing research connection

Cellular NAD+ levels are documented to decline with age across multiple model organisms. Whether that decline is a cause of age-related dysfunction, a consequence of it, or both, remains an open question and an active area of investigation. This is the basis of most longevity-adjacent research interest in the molecule, and it is worth stating plainly that the causal picture is not settled.

Precursors versus NAD+ itself

Much of the literature concerns precursors — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — rather than NAD+ directly. The reason is practical: NAD+ is a relatively large, charged molecule, and cellular uptake is a genuine experimental obstacle. Precursors enter cells more readily and are converted internally.

Anyone designing a study around NAD+ should be clear about which they mean, because the two produce different experimental questions.

How it relates to peptide research

NAD+ is often grouped alongside MOTS-c and similar compounds under a metabolic-research heading. The connection is thematic rather than structural — both concern mitochondrial function and cellular energetics — but NAD+ is a coenzyme, not a peptide, and the distinction is worth preserving.

Handling

NAD+ is supplied as a lyophilised powder and is sensitive to moisture and heat. Standard practice on reconstitution and storage applies.

Availability

We supply NAD+ 100mg for laboratory research.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

Bacteriostatic water and sterile water look identical and are often used interchangeably in conversation, but they are not the same product. The difference is a single ingredient — a preservative — and it determines whether a vial can be used once or many times.

The short answer

Sterile water is purified water that has been sterilised. It contains nothing else. Once the seal is broken, it offers no protection against microbial growth.

Bacteriostatic water is sterile water with roughly 0.9% benzyl alcohol added. Benzyl alcohol is a bacteriostatic preservative: it inhibits bacterial growth rather than killing bacteria outright. This allows the vial to be entered repeatedly over a period of time.

Side by side

Bacteriostatic, not bactericidal

This distinction is worth being precise about. Bacteriostatic means growth is inhibited. Bactericidal means organisms are killed. Benzyl alcohol is the former. It suppresses proliferation; it does not sterilise a contaminated vial, and it does not compensate for poor aseptic technique.

Which is used for reconstitution?

Bacteriostatic water is the standard choice for reconstituting lyophilised research peptides, precisely because a 5mg or 10mg vial is rarely consumed in a single measurement. The preservative gives the reconstituted solution a usable working window.

Sterile water is appropriate where the entire volume is used at once, or where benzyl alcohol would interfere with the assay — some sensitive cell-culture applications, for example.

What about acetic acid?

A third option appears occasionally. Peptides with poor aqueous solubility may require a small quantity of dilute acetic acid to dissolve fully, after which the stock can be diluted with an appropriate buffer. Our Reconstitution & Storage guide covers solvent selection, along with concentration and stability calculators.

Storage after reconstitution

Whichever solvent is used, a reconstituted peptide is far less stable than the freeze-dried powder. Refrigerate between uses, avoid repeated freeze-thaw cycles, and aliquot before freezing if longer storage is needed. See our notes on storing lyophilised peptides.

Availability

We supply Bacteriostatic Water 10ml to support reconstitution in laboratory research.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

GHK-Cu is a naturally occurring copper-binding tripeptide studied extensively in skin, collagen and tissue-remodelling research. Unlike most research peptides, it is not a synthetic construct — it occurs in human plasma, and its concentration is documented to decline with age.

What is GHK-Cu?

The peptide itself is GHK: glycine, histidine and lysine, three amino acids in sequence. What makes it distinctive is its exceptionally high affinity for copper(II) ions. The bound complex, GHK-Cu, is the form studied in most of the literature, and the copper is not incidental — it is central to the peptide’s biochemistry.

Why copper matters

Copper is a cofactor for several enzymes involved in connective tissue formation, including lysyl oxidase, which cross-links collagen and elastin. GHK appears to act partly as a copper delivery vehicle, moving the ion in a form that cells can take up in a controlled way. Free copper is reactive and potentially damaging; complexed copper is not.

This is one reason GHK-Cu is often discussed in the context of tissue remodelling rather than as a simple signalling molecule.

What is it studied for?

Research interest clusters around several areas:

• Collagen and extracellular matrix — investigating its influence on synthesis and organisation of structural proteins.
• Skin research — a large body of cosmetic-science literature examines GHK-Cu in dermal contexts, which is why it appears in ingredient lists.
• Gene expression — work has explored its apparent influence on broad transcriptional patterns, an unusual property for so small a molecule.
• Wound and tissue repair models — preclinical work on regeneration pathways.

How it differs from repair peptides

GHK-Cu is frequently grouped with BPC-157 and TB-500 under a general “repair” heading, but the mechanisms are unrelated. Those two are studied for their influence on cell migration and angiogenesis pathways; GHK-Cu is a copper-transport tripeptide with matrix-level effects. Grouping them by outcome obscures that they work by entirely different routes.

Handling notes

GHK-Cu solutions are characteristically blue, a direct consequence of the coordinated copper ion. This is expected and is not a sign of contamination. As with all research peptides, follow standard practice on reconstitution and storage — see our Reconstitution & Storage guide.

Availability

We supply GHK-Cu 50mg for laboratory research.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

GHRP-2 and GHRP-6 are both growth hormone releasing peptides that bind the same receptor, yet they behave differently enough that the choice between them meaningfully shapes an experiment. The clearest divergence is appetite signalling.

What they have in common

Both are synthetic ghrelin mimetics that act at the growth hormone secretagogue receptor (GHS-R). Both belong to the wider secretagogue class, and both are studied for their influence on endogenous growth hormone release rather than for supplying growth hormone directly.

Where they differ

The appetite question

GHRP-6 is strongly associated in the literature with appetite stimulation, an effect consistent with its action at the ghrelin receptor. GHRP-2 produces a comparatively modest effect. This is not a minor footnote — if a study is examining growth hormone signalling and the compound also drives a substantial feeding response, that confound has to be controlled for.

Conversely, if appetite regulation is itself the object of study, GHRP-6 becomes the more informative tool.

Selectivity and the Ipamorelin comparison

Both GHRPs are documented as producing measurable effects on cortisol and prolactin alongside growth hormone. This is the specific limitation that later compounds sought to address: Ipamorelin was developed as a more selective agonist at the same receptor, with reduced cross-reactivity.

The practical consequence is a trade-off. The GHRPs are potent and well-characterised; Ipamorelin is cleaner but acts differently. Which is “better” depends entirely on the question being asked, and any supplier claiming one is universally superior is overselling.

Are they interchangeable?

No. They share a receptor, but they are not equivalent inputs. Substituting one for the other mid-study introduces a variable that will affect appetite-related measures, potency, and possibly hormonal cross-effects.

Availability

We supply GHRP-2 10mg and GHRP-6 10mg for laboratory research. Batch documentation is available on applicable products — see Quality & Testing.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

Ipamorelin is a synthetic pentapeptide studied as a selective agonist of the growth hormone secretagogue receptor. It is frequently described in the literature as one of the more selective compounds in its class, which is the main reason it appears so often in controlled experimental work.

What is Ipamorelin?

Ipamorelin is a chain of five amino acids designed to mimic ghrelin, the naturally occurring peptide that binds the growth hormone secretagogue receptor (GHS-R). It belongs to the ghrelin-mimetic family rather than the GHRH family, meaning it acts on a completely different receptor from compounds such as CJC-1295.

What does “selective” mean here?

Selectivity is the property that defines Ipamorelin in research contexts. Earlier ghrelin mimetics, including the GHRPs, are documented as producing measurable effects on other hormones alongside growth hormone — cortisol and prolactin among them. Ipamorelin was developed specifically to reduce that cross-reactivity.

For a researcher, this matters enormously. If a compound perturbs several hormonal axes at once, it becomes difficult to attribute an observed outcome to any single mechanism. A more selective tool produces a cleaner experiment.

How it differs from GHRH analogues

The two families are complementary rather than competing:

• GHRH analogues (CJC-1295, Sermorelin, Tesamorelin) bind the GHRH receptor.
• Ghrelin mimetics (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) bind GHS-R.

Because these are separate receptors on the same cells, researchers commonly examine them in combination to study whether the pathways interact additively or synergistically. We explore that specific question in our article on why CJC-1295 and Ipamorelin are studied together.

Appetite and the ghrelin connection

Ghrelin is often called the “hunger hormone”, and compounds that mimic it can influence appetite signalling. Notably, Ipamorelin is documented as producing markedly less appetite stimulation than GHRP-6, despite both acting at the same receptor. That divergence is itself a subject of research interest, since it suggests receptor activation is not a single uniform event.

Handling

Ipamorelin is supplied as a lyophilised powder. As with all research peptides, it should be reconstituted carefully and stored appropriately — see our Reconstitution & Storage guide and our notes on storing lyophilised peptides.

Availability

We supply Ipamorelin 5mg for laboratory research, with batch documentation available on applicable products.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) used in laboratory research into the endocrine pathways that regulate growth hormone. It appears widely in preclinical literature examining how GHRH receptor signalling influences pulsatile hormone release.

What is CJC-1295?

CJC-1295 is a modified peptide based on the first 29 amino acids of naturally occurring GHRH — the fragment responsible for receptor binding. Several amino acid substitutions were introduced to slow enzymatic breakdown, which is the principal limitation of native GHRH in experimental settings, where it degrades within minutes.

The compound exists in two distinct research forms. One incorporates a Drug Affinity Complex (DAC) that extends its presence in circulation considerably. The other omits it, and is frequently listed as CJC-1295 without DAC, or Modified GRF (1-29). The difference is substantial enough that the two are not interchangeable in study design, and we cover it in detail in our companion article on CJC-1295 with DAC versus without DAC.

How is it studied?

Research interest centres on the GHRH receptor, found on somatotroph cells of the anterior pituitary. Laboratory investigation typically examines how binding at this receptor influences the release of endogenous growth hormone, and how that release pattern differs from direct hormone administration.

A recurring theme in the literature is that GHRH analogues appear to amplify the body’s own signalling rather than replace it, meaning existing feedback mechanisms remain in play. This makes them useful tools for studying regulatory control rather than simply elevating hormone levels.

Why is it grouped with secretagogues?

CJC-1295 belongs to the broader class of growth hormone secretagogues. Within that class it acts on the GHRH receptor, while others — the ghrelin mimetics such as Ipamorelin and the GHRPs — act on an entirely separate receptor. Researchers frequently examine the two pathways together precisely because they are distinct.

Handling and stability

Like most research peptides, CJC-1295 is supplied as a lyophilised powder and must be reconstituted before laboratory use. Reconstituted solutions have a considerably shorter stability window than the freeze-dried form, and repeated freeze-thaw cycles degrade peptide structure. Our Reconstitution & Storage guide covers general laboratory practice, including calculators for concentration and stability.

Verifying what you have

Peptide identity and purity cannot be assessed by eye. Analytical verification — typically HPLC for purity and mass spectrometry for identity — is what distinguishes a characterised research compound from an unknown powder. See why Certificates of Analysis matter.

Availability

We supply both forms for laboratory research: CJC-1295 Without DAC 5mg and CJC-1295 With DAC 5mg.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

CJC-1295 and Ipamorelin appear together throughout the research literature for a straightforward reason: they act on two different receptors that converge on the same cell. Studying them in combination lets researchers ask whether those two signals simply add together, or amplify one another.

Two receptors, one cell

Growth hormone is released from somatotroph cells in the anterior pituitary. Those cells carry two separate receptors relevant here:

• The GHRH receptor, which CJC-1295 binds as a GHRH analogue.
• The growth hormone secretagogue receptor (GHS-R), which Ipamorelin binds as a ghrelin mimetic.

Because these are distinct receptors with distinct downstream signalling cascades, activating both simultaneously is not the same as activating either one twice.

What the pairing is used to investigate

The central research question is whether the combined signal is additive (the sum of the two) or synergistic (greater than the sum). Preclinical work has explored this extensively, and the pairing has become a standard model for examining how convergent pathways integrate at the cellular level.

A secondary line of enquiry concerns somatostatin, the inhibitory hormone that suppresses growth hormone release. Ghrelin-receptor agonists are documented as reducing somatostatin’s inhibitory tone, which may be part of why the combination behaves differently from either compound alone.

Why researchers care about the pulse shape

As covered in our overview of growth hormone secretagogues, endogenous growth hormone is released in pulses rather than continuously. Combination studies are often designed to examine the shape of that pulse — its amplitude, its duration, how quickly it resolves — rather than a single peak measurement.

This is also why the choice between CJC-1295 with DAC and without DAC materially changes the experiment. The short-acting form preserves pulsatility; the DAC form does not. Our comparison of with DAC versus without DAC sets out the difference.

An important caution

The volume of informal discussion around this pairing far exceeds the volume of controlled human evidence. Much of what circulates online treats preclinical findings as though they translate directly, which they do not. These compounds are laboratory tools, and the appropriate framing is mechanism, not outcome.

Availability

Both compounds are supplied for laboratory research. See CJC-1295 Without DAC 5mg, CJC-1295 With DAC 5mg and Ipamorelin 5mg, or browse our research bundles.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.

The difference between CJC-1295 with DAC and without DAC comes down to one thing: how long the peptide persists in circulation. With DAC it lasts for days; without DAC, for minutes. That single property changes how each is used in research, and the two are not substitutes for one another.

What does DAC actually mean?

DAC stands for Drug Affinity Complex. It is a chemical addition that allows the peptide to bind reversibly to albumin, an abundant carrier protein in blood. Bound to albumin, the peptide is shielded from the enzymes that would otherwise clear it, and is released gradually over time.

Without that addition, the peptide is simply the modified GHRH fragment on its own — commonly listed as CJC-1295 Without DAC, or Modified GRF (1-29).

The practical difference

Why the half-life matters so much

Growth hormone is not released continuously. It is released in pulses, and the shape and timing of those pulses is itself biologically meaningful. This is why the two forms answer genuinely different research questions.

The version without DAC produces a brief, sharp signal that more closely resembles the body’s own release pattern. Researchers studying pulsatility, receptor sensitivity, or the natural rhythm of secretion tend to work with this form.

The DAC version, by contrast, maintains an elevated signal over a much longer window. That is useful for investigating what happens when receptor exposure is sustained rather than intermittent — including questions about receptor desensitisation, which pulsatile signalling appears to avoid.

Which is which on a label?

Naming in this area is genuinely inconsistent across suppliers, which is a common source of confusion. “CJC-1295” alone is ambiguous. Some vendors use it to mean the DAC version; others use it to mean the fragment. Always check whether DAC is explicitly stated, and confirm against the batch documentation rather than the product name.

This is one reason we list them as separate products with distinct SKUs, and why a Certificate of Analysis is worth reading before use — mass spectrometry confirms molecular weight, and the two forms differ.

Are they used together?

Rarely, and it would be unusual to combine them, since they occupy the same receptor. Far more common in the literature is pairing either form with a ghrelin-receptor compound such as Ipamorelin, because those act on a separate pathway.

Both forms are available for laboratory research: CJC-1295 With DAC 5mg and CJC-1295 Without DAC 5mg.

For Research Use Only. Not for Human Consumption. This article is provided for laboratory research and educational purposes only. It does not constitute medical advice, and no dosing or administration guidance is offered or implied. Products supplied by Qube Peptides are not medicines, are not dietary supplements, and are not intended for human or veterinary use.